Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1640, 2008-01, pp. : 18-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
ACE inhibitors reduce CV risk in patients with atherosclerosis
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :
Access to resources
Recommend
Folic acid and B vitamins reduce homocysteine but not CV risk
Inpharma, Vol. 1, Iss. 1638, 2008-01 ,pp. :
Diabetes DM programme worthwhile to reduce CV risk factors
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 477, 2005-01 ,pp. :
Zafirlukast effective in asthma regardless of age
Inpharma, Vol. 1, Iss. 1234, 2000-01 ,pp. :
Simvastatin a winner regardless of vascular risk level
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. :